Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma

Yuichi Nakashima(Shimane University), Naofumi Nagasue(Shimane University), Osama N. El‐Assal(Akron Children's Hospital), Hitoshi Kohno, Akira Yamanoi(Shimane University), Takashi Ono(Shionogi (Japan))

Journal of Gastroenterology

August 1, 2004

10.1007/s00535-003-1386-2

Cited by 69

Related Papers

Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver

|Hepatology|1998|324

Opposing roles of STAT1 and STAT3 in T cell–mediated hepatitis: regulation by SOCS

|Journal of Clinical Investigation|2002|270

Opposing roles of STAT1 and STAT3 in T cell–mediated hepatitis: regulation by SOCS

|Journal of Clinical Investigation|2002|243

Cannabinoid‐2 receptor mediates protection against hepatic ischemia/reperfusion injury

|The FASEB Journal|2007|240

The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.

|PubMed|2001|195